SCIENTURE HOLDINGS, INC. Equity Method Investments
SCIENTURE HOLDINGS, INC. (SCNX) had Equity Method Investments of $0 as of 2021-12-31, per its 10-K filed 2022-03-28.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:EquityMethodInvestments · last filed 2022-03-28
- 2021-12-31: Equity Method Investments $0.00.
- 2019-06-30: Equity Method Investments $162.18K.
- 2019-03-31: Equity Method Investments $221.03K.
| Period end | Equity Method Investments |
|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-28 |
| 2019-06-30 | $162.18K 10-Q · filed 2019-07-26 |
| 2019-03-31 | $221.03K 10-Q · filed 2019-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |